Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

被引：0
|
作者：
Jinwen Shen
Xiu Zhu
Yian Du
Yuan Zhu
Pengfei Yu
Litao Yang
Zhiyuan Xu
Ling Huang
Yunli Zhang
Yanqiang Zhang
Luying Liu
Xiangdong Cheng
机构：
[1] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Radiotherapy
[2] Zhejiang Provincial Research Center for Cancer of Upper Gastrointestinal Tract,Department of Pathology
[3] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Surgery
[4] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),undefined
来源：
Trials | / 22卷
关键词：
Esophagogastric junction adenocarcinoma; D2 radical resection; Adjuvant chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)
    Shen, Jinwen
    Zhu, Xiu
    Du, Yian
    Zhu, Yuan
    Yu, Pengfei
    Yang, Litao
    Xu, Zhiyuan
    Huang, Ling
    Zhang, Yunli
    Zhang, Yanqiang
    Liu, Luying
    Cheng, Xiangdong
    TRIALS, 2021, 22 (01)
  • [2] Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
    Kang, Wen-Zhe
    Shi, Jin-Ming
    Wang, Bing-Zhi
    Xiong, Jian-Ping
    Shao, Xin-Xin
    Hu, Hai-Tao
    Jin, Jing
    Tian, Yan-Tao
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (08) : 1540 - 1551
  • [3] Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type Ⅱ/Ⅲ adenocarcinoma of gastroesophageal junction after D2/R0 resection
    Wen-Zhe Kang
    Jin-Ming Shi
    Bing-Zhi Wang
    Jian-Ping Xiong
    Xin-Xin Shao
    Hai-Tao Hu
    Jing Jin
    Yan-Tao Tian
    World Journal of Gastrointestinal Oncology, 2022, 14 (08) : 1540 - 1551
  • [4] Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT
    Xiaowen Liu
    Jiejie Jin
    Hong Cai
    Hua Huang
    Guangfa Zhao
    Ye Zhou
    Jianghong Wu
    Chunyan Du
    Ziwen Long
    Yantian Fang
    Mingze Ma
    Guichao Li
    Menglong Zhou
    Jiliang Yin
    Xiaodong Zhu
    Ji zhu
    Weiqi Sheng
    Dan Huang
    Hui Zhu
    Zhaozhen Zhang
    Qi Lu
    Li Xie
    Zhen Zhang
    Yanong Wang
    BMC Cancer, 19
  • [5] Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT
    Liu, Xiaowen
    Jin, Jiejie
    Cai, Hong
    Huang, Hua
    Zhao, Guangfa
    Zhou, Ye
    Wu, Jianghong
    Du, Chunyan
    Long, Ziwen
    Fang, Yantian
    Ma, Mingze
    Li, Guichao
    Zhou, Menglong
    Yin, Jiliang
    Zhu, Xiaodong
    Zhu, Ji
    Sheng, Weiqi
    Huang, Dan
    Zhu, Hui
    Zhang, Zhaozhen
    Lu, Qi
    Xie, Li
    Zhang, Zhen
    Wang, Yanong
    BMC CANCER, 2019, 19 (1)
  • [6] Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
    Shi, Jinming
    Kang, Wenzhe
    Tang, Yuan
    Li, Ning
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Yexiong
    Tian, Yantao
    Jin, Jing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] A Multicenter Phase III Randomized Clinical Trial Comparing the Efficacy of an Adjuvant SOX Chemotherapy Regimen with SOX Combined with a Simultaneous Radiotherapy Regimen after D2 Radical Resection for Gastric Cancer
    Wang, X.
    Yan, O.
    Shen, Y.
    Li, Z.
    Li, Q.
    Cao, D.
    Qiu, M.
    Liu, J.
    Wang, W.
    Gou, H.
    Liu, M.
    Yi, C.
    Yang, Y.
    Zhu, Q.
    Luo, D.
    Zhou, J.
    Zhao, Y.
    Chen, Y.
    Wang, S.
    Wang, Q.
    Cheng, K.
    Ren, M.
    Wen, F.
    Cai, X.
    Tan, S.
    Wang, Z.
    Qiao, Q.
    Liu, X.
    Xu, F.
    Bi, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S5 - S5
  • [8] ACTLACC TRIAL: A PHASE III RANDOMIZED TRIAL COMPARING ADJUVANT CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION VERSUS CONCURRENT CHEMORADIATION ALONE FOR LOCALLY ADVANCED CERVICAL CANCER
    Tangjitgamol, S.
    Tharavichitkul, E.
    Tovanabutra, C.
    Rongsriyam, K.
    Asakij, T.
    Paengchit, K.
    Sukhaboon, J.
    Penpattanagul, S.
    Kridakara, G. C. A.
    Hanprasertpong, J.
    Chomprasert, K.
    Wanglikitkoon, S.
    Atjimakul, T.
    Pariyawateekul, S. L. P.
    Katanyoo, K.
    Tanprasert, P.
    Janweerachai, W.
    Khunnarong, J.
    Srisomboon, J.
    Lorvidhaya, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 6 - 7
  • [9] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
    Ji, J.
    Shen, L.
    Li, Z.
    Zhang, X.
    Liang, H.
    Xue, Y.
    Wang, Y.
    Zhou, Z.
    Yu, J.
    Chen, L.
    Du, Y.
    Li, G.
    Xiao, G.
    Wu, D.
    Zhou, Y.
    Dang, C.
    He, Y.
    Zhang, Z.
    Sun, Y.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877
  • [10] Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: First results of a randomized phase III trial
    Stahl, M.
    Walz, M. K.
    Stuschke, M.
    Lehmann, N.
    Seegenschmiedt, M. H.
    Knorrenschild, J. Riera
    Langer, P.
    Bieker, M.
    Koenigsrainer, A.
    Budach, W.
    Wilke, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345